RCUS stock forecast
Our latest prediction for Arcus Biosciences, Inc.'s stock price was made on the June 6, 2019 when the stock price was at 7.99$.
In the short term (2weeks), RCUS's stock price should outperform the market by 3.30%. During that period the price should oscillate between -7.72% and +13.42%.
In the medium term (3months), RCUS's stock price should outperform the market by 3.78%. During that period the price should oscillate between -18.75% and +33.88%.Get email alerts
Create a solid portfolio with RCUS
About Arcus Biosciences, Inc.
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
At the moment the company generates 9M USD in revenues.
On its last earning announcement, the company reported a loss of -1.47$ per share.
The book value per share is 5.73$
Three months stock forecastJune 6, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|